These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 17054858

  • 1. [Cytokine-induced killer cell fusion to lower recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization sequentially combined with radiofrequency ablation: a randomized trial].
    Zhao M, Wu PH, Zeng YX, Xia JC, Zhang FJ, Xian LJ, Zhang YP, Zhou K, Fan WJ, Zhang L, Gao F, Zhou QM.
    Zhonghua Yi Xue Za Zhi; 2006 Jul 11; 86(26):1823-8. PubMed ID: 17054858
    [Abstract] [Full Text] [Related]

  • 2. [Short-term curative efficacy of cytokine-induced killer cells combined micro-invasive treatments on hepatocellular carcinoma].
    Zhou QM, Wu PH, Zhao M, Wang QJ, Huang LX, Li YQ, Chen SP, Xia JC.
    Ai Zheng; 2006 Nov 11; 25(11):1414-8. PubMed ID: 17094912
    [Abstract] [Full Text] [Related]

  • 3. Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients.
    Huang ZM, Li W, Li S, Gao F, Zhou QM, Wu FM, He N, Pan CC, Xia JC, Wu PH, Zhao M.
    J Immunother; 2013 Jun 11; 36(5):287-93. PubMed ID: 23719239
    [Abstract] [Full Text] [Related]

  • 4. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
    Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS.
    Ai Zheng; 2005 Jul 11; 24(7):827-33. PubMed ID: 16004809
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, Zhang L, Li XS, Pan CC, Wu PH.
    Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1167-72. PubMed ID: 21756768
    [Abstract] [Full Text] [Related]

  • 6. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
    Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, Watanabe T, Mine T, Tokai RFA Study Group.
    Cancer; 2010 Aug 01; 116(15):3638-44. PubMed ID: 20564097
    [Abstract] [Full Text] [Related]

  • 7. Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: report of a prospective study.
    Park JW, Park KW, Cho SH, Park HS, Lee WJ, Lee DH, Kim CM.
    Am J Gastroenterol; 2005 Oct 01; 100(10):2194-200. PubMed ID: 16181368
    [Abstract] [Full Text] [Related]

  • 8. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
    Li CX, Wu PH, Fan WJ, Huang JH, Zhang FJ, Zhang L, Gu YK, Zhao M, Gao F, Jiao DC.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 24; 89(11):754-7. PubMed ID: 19595104
    [Abstract] [Full Text] [Related]

  • 9. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Gao HJ, Liang HH, Chen MS, Peng ZW, Zhang YJ, Li P, Pang XH, Zhang YQ, Li JQ.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 23; 88(36):2529-32. PubMed ID: 19080642
    [Abstract] [Full Text] [Related]

  • 10. Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas.
    Weng DS, Zhou J, Zhou QM, Zhao M, Wang QJ, Huang LX, Li YQ, Chen SP, Wu PH, Xia JC.
    J Immunother; 2008 Jan 23; 31(1):63-71. PubMed ID: 18157013
    [Abstract] [Full Text] [Related]

  • 11. [Appraisal of postoperative transcatheter arterial chemoembolization (TACE) for prevention and treatment of hepatocellular carcinoma recurrence].
    Lin Z, Ren Z, Xia J.
    Zhonghua Zhong Liu Za Zhi; 2000 Jul 23; 22(4):315-7. PubMed ID: 11778559
    [Abstract] [Full Text] [Related]

  • 12. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM, Qin H, Wang CB, Fang XH, Ma QY.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 23; 29(3):232-5. PubMed ID: 17649645
    [Abstract] [Full Text] [Related]

  • 13. [Radiofrequency ablation with or without transcather arterial chemoembolization for management of hepatocellular carcinoma].
    Li ZR, Kang Z, Qian JS, Zhu KS, Jiang ZB, Huang MS, Guan SH, Shan H.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov 23; 27(11):1749-51. PubMed ID: 18024306
    [Abstract] [Full Text] [Related]

  • 14. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, Hamada T, Iida T, Nakamura I, Fujii K, Usui M, Isaji S, Ito K, Tagawa S, Takeda K, Yokoi H, Noguchi T.
    J Gastroenterol Hepatol; 2008 Mar 23; 23(3):482-90. PubMed ID: 18086115
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
    Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW.
    Korean J Hepatol; 2009 Dec 23; 15(4):474-85. PubMed ID: 20037266
    [Abstract] [Full Text] [Related]

  • 16. Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.
    Pan CC, Huang ZL, Li W, Zhao M, Zhou QM, Xia JC, Wu PH.
    Chin J Cancer; 2010 Jun 23; 29(6):596-602. PubMed ID: 20507732
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of combined percutaneous radio-frequency ablation and percutaneous ethanol injection after transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhang FJ, Wu PH, Zhao M, Gu YK, Zhang L, Tan ZB.
    Zhonghua Zhong Liu Za Zhi; 2005 Apr 23; 27(4):248-50. PubMed ID: 15949431
    [Abstract] [Full Text] [Related]

  • 18. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.
    Bloomston M, Binitie O, Fraiji E, Murr M, Zervos E, Goldin S, Kudryk B, Zwiebel B, Black T, Fargher S, Rosemurgy AS.
    Am Surg; 2002 Sep 23; 68(9):827-31. PubMed ID: 12356160
    [Abstract] [Full Text] [Related]

  • 19. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC.
    Yang P, Liang M, Zhang Y, Shen B.
    Adv Ther; 2008 Aug 23; 25(8):787-94. PubMed ID: 18670743
    [Abstract] [Full Text] [Related]

  • 20. [Therapeutic effect and prognosis of interferon therapy after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma associated with hepatitis B virus].
    Gao J, Li XS, Shen W, Wu XC, Feng XX, Ren H.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug 23; 12(8):460-2. PubMed ID: 15329203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.